Showing 1 - 8 results of 8 for search 'Pablo Lopez-Bergami', query time: 0.03s Refine Results
  1. 1
    ROR2, a driver of “phenotype switching” in melanoma?

    ROR2, a driver of “phenotype switching” in melanoma? by Pablo Lopez-Bergami

    Published 2022-09-01
    Get full text
    Article
  2. 2
    ROR2 increases the chemoresistance of melanoma by regulating p53 and Bcl2-family proteins via ERK hyperactivation

    ROR2 increases the chemoresistance of melanoma by regulating p53 and Bcl2-family proteins via ERK hyperactivation by María Victoria Castro, Gastón Alexis Barbero, Paula Máscolo, Rocío Ramos, María Josefina Quezada, Pablo Lopez-Bergami

    Published 2022-03-01
    Get full text
    Article
  3. 3
    Correction to: ROR2 increases the chemoresistance of melanoma by regulating p53 and Bcl2-family proteins via ERK hyperactivation

    Correction to: ROR2 increases the chemoresistance of melanoma by regulating p53 and Bcl2-family proteins via ERK hyperactivation by María Victoria Castro, Gastón Alexis Barbero, Paula Máscolo, Rocío Ramos, María Josefna Quezada, Pablo Lopez-Bergami

    Published 2022-07-01
    Get full text
    Article
  4. 4
    An Autocrine Wnt5a Loop Promotes NF-κB Pathway Activation and Cytokine/Chemokine Secretion in Melanoma

    An Autocrine Wnt5a Loop Promotes NF-κB Pathway Activation and Cytokine/Chemokine Secretion in Melanoma by Gastón Barbero, María Victoria Castro, María Belén Villanueva, María Josefina Quezada, Natalia Brenda Fernández, Sharon DeMorrow, Pablo Lopez-Bergami

    Published 2019-09-01
    Get full text
    Article
  5. 5
    BCL2L10 Is Overexpressed in Melanoma Downstream of STAT3 and Promotes Cisplatin and ABT-737 Resistance

    BCL2L10 Is Overexpressed in Melanoma Downstream of STAT3 and Promotes Cisplatin and ABT-737 Resistance by María Josefina Quezada, María Elisa Picco, María Belén Villanueva, María Victoria Castro, Gastón Barbero, Natalia Brenda Fernández, Edith Illescas, Pablo Lopez-Bergami

    Published 2020-12-01
    Get full text
    Article
  6. 6
    ROR2 has a protective role in melanoma by inhibiting Akt activity, cell-cycle progression, and proliferation

    ROR2 has a protective role in melanoma by inhibiting Akt activity, cell-cycle progression, and proliferation by María Victoria Castro, Gastón Alexis Barbero, María Belén Villanueva, Luca Grumolato, Jérémie Nsengimana, Julia Newton-Bishop, Edith Illescas, María Josefina Quezada, Pablo Lopez-Bergami

    Published 2021-11-01
    Get full text
    Article
  7. 7
    β-Catenin-independent activation of TCF1/LEF1 in human hematopoietic tumor cells through interaction with ATF2 transcription factors.

    β-Catenin-independent activation of TCF1/LEF1 in human hematopoietic tumor cells through interaction with ATF2 transcription factors. by Luca Grumolato, Guizhong Liu, Tomomi Haremaki, Sathish Kumar Mungamuri, Phyllus Mong, Gal Akiri, Pablo Lopez-Bergami, Adriana Arita, Youssef Anouar, Marek Mlodzik, Ze'ev A Ronai, Joshua Brody, Daniel C Weinstein, Stuart A Aaronson

    Published 2013-01-01
    Get full text
    Article
  8. 8
    Bcl-2-like protein-10 increases aggressive features of melanoma cells

    Bcl-2-like protein-10 increases aggressive features of melanoma cells by Donatella Del Bufalo, Marta Di Martile, Elisabetta Valentini, Isabella Manni, Ilenia Masi, Antonella D'Amore, Antonio Filippini, Carmine Nicoletti, Marco Zaccarini, Carlo Cota, Maria Victoria Castro, María Josefina Quezada, Laura Rosanò, Pablo Lopez-Bergami, Simona D'Aguanno

    Published 2022-01-01
    Get full text
    Article

Search Tools: